Professional
Added to YB: 2025-02-17
Pitch date: 2025-02-06
RVTY [bullish]
Revvity, Inc.
-19.59%
current return
Author Info
No bio for this author
Company Info
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Market Cap
$10.6B
Pitch Price
$118.61
Price Target
N/A
Dividend
0.29%
EV/EBITDA
14.47
P/E
45.49
EV/Sales
4.51
Sector
Life Sciences Tools and Services
Category
turnaround
Bretton Fund Portfolio Holding: Revvity, Inc.
RVTY: Ex-PerkinElmer pivots post-Covid. Now focused on reagents (75k products) & immunodiagnostics. Smaller units: lab software & newborn screening. Healthcare industry hangover after Covid windfall. 2.4% gain last year, trades at 23x earnings. Simplified portfolio after acquisitions & disposals.
Read full article (1 min)